Spectrum of β-thalassemia mutations in the eastern province of Saudi Arabia

Hemoglobin

Volumn 35, Issue 2, 2011, Pages 125-134

  Al Sultan, Ali ^a   Phanasgaonkar, Supriya ^a   Suliman, Ahmed ^b   Al Baqushi, Muneer ^b   Nasrullah, Zaki ^c   Al Ali, Amein ^d  

^a KING FAISAL UNIVERSITY   (Saudi Arabia)

^b KING FAHAD HOSPITAL   (Saudi Arabia)

^c Maternity and Children Hospital   (Saudi Arabia)

^d IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Thalassemia; Anemia; Heterozygous; Mutation

Indexed keywords

ARTICLE; BETA THALASSEMIA; CHILD; CODON; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; NONSENSE MUTATION; PREVENTION STUDY; RNA SPLICING; SAUDI ARABIA; SCHOOL CHILD; SCREENING; SICKLE CELL;

ADOLESCENT; ALLELES; BETA-THALASSEMIA; CHILD; CHILD, PRESCHOOL; FEMALE; GENE FREQUENCY; GENOTYPE; HEMOGLOBIN, SICKLE; HUMANS; MALE; MUTATION; SAUDI ARABIA;

EID: 79952924677     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.3109/03630269.2011.553567     Document Type: Article

References (28)

1. Steinberg MH, Forget BG, Higgs DR, Weatherall DJ. Disorders of Hemoglobin: Genetics, Pathophysiology and Clinical Management. Cambridge: Cambridge University Press, 2001.
2. Weatherall DJ. The thalassaemias. In: Stamatoyannopoulos G, Majerus PH, Varmus H, Nienhuis AW, eds. The Molecular Basis of Blood Diseases. Philadelphia, PA: W. B. Saunders Company; 1994: 157-205.
3. Thein SL. Genetic modifiers of β-thalassemia. Haematologica. 2005;90(5):649-660.
4. Galanello R, Origa R. β-Thalassemia. J Rare Dis. 2010;5:11-25.
5. Uda M, Galanello R, Sanna S, Lettre G, Sankaran VG, Chen W, et al. Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of phenotype of β-thalassemia. Proc Natl Acad Sci USA. 2008;105:1620-1625. (Pubitemid 351346564)
6. Hardison RC, Chui DHK, Giardine B, Riemer C, Patrinos GP, Anagnou N, et al. HbVar: a relational database of human hemoglobin variants and thalassemia mutations at the globin gene server. Hum Mutat. 2002;19(3):225-331 (http//globin.cse.psu.edu).
7. Flint J, Harding RM, Boyce AJ, Clegg JB. The population genetics of the haemoglobinopathies. Baillière's Clin Haematol. 1998;11(1):1-51. (Pubitemid 29039017)
8. Cao A, Gossens M, Pirastu M. β-Thalassaemia mutations in Mediterranean populations. Br J Haematol. 1989; 71(3):309-312.
9. Zahed L. The spectrum of β-thalassaemia mutations in the Arab populations. J Biomed Biotechnol. 2001;1(3):129-132. (Pubitemid 46842819)
10. El-Hazmi MA, Al-Swailem AR, Warsy AS. Molecular defects in β-thalassaemias in the population of Saudi Arabia. Hum Hered. 1995;45(5):278-285.
11. Hasounah FH, Sejeny SA, Omer JA, Old JM, Oliver RW. Spectrum of β-thalassaemia mutations in the population of Saudi Arabia. Hum Hered. 1995;45(4):231-234.
12. El-Harth EH, Kuhnau W, Schmidtke J, Stuhrmann M, Nasserallah Z, Al-Shahiri A. Identification and clinical presentation of β thalassaemia mutations in the Eastern region of Saudi Arabia. J Med Genet. 1999;36(12):935-937. (Pubitemid 30003856)
13. Al-Ali AK, Al-Ateeq S, Mamwerdi BW, Al-Sowayan S, Al-Madan M, Al-Muhanna F, et al. Molecular bases of β-thalassemia in the Eastern Province of Saudi Arabia. J Biomed Biotechnol. 2005:4:1-4.
14. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215-1216.
15. Pembrey ME, Perrine RP, Wood WG, Weatherall DJ. Sickle β0 thalassemia in the Eastern Saudi Arabia. Am J Hum Genet. 1980;32(1):26-41. (Pubitemid 10154991)
16. Perrine RP, Pembrey ME, John P, Perrine S, Shoup F. Natural history of sickle cell anemia in Saudi Arabs. A study of 270 subjects. Ann Intern Med. 1978;88(1):1-6. (Pubitemid 8265449)
17. Henderson S, Timbs A, McCarthy J, Gallienne A, Van Mourik M, Masters G, et al. Incidence of haemoglobinopathies in various populations - the impact of immigration. Clin Biochem. 2009;42(18):1745-1756.
18. Jassim N, Merghoub T, Pascaud O, al Mukharraq H, Ducrocq R, Labie D, et al. Molecular basis of β-thalassemia in Bahrain: an epicenter for a Middle East specific mutation. Ann NY Acad Sci. 1988;850:407-409.
19. Adekile AD, Gu L-H, Baysal E, Haider MZ, al-Fuzae L, Aboobacker KC, et al. Molecular characterization of α-thalassemia determinants, β-thalassemia alleles, and βS haplotypes among Kuwaiti Arabs. Acta Haematol. 1994;92(4):176-181.
20. Quaife R, al-Gazali L, Abbes S, Fitzgerald P, Fitches A, Valler D, et al. The spectrum of β-thalassemia mutations in the UAE national population. J Med Genet. 1994;31(1):59-61. (Pubitemid 24037949)
21. Daar S, Hussein HM, Merghoub T, Krishnamoorthy R. Spectrum of β-thalassemia mutations in Oman. Ann NY Acad Sci. 1998;850:404-406.
22. Patrinos GP, Giardine B, Riemer C, Miller W, Chui DH, Anagnou NP, et al. Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studies. Nucleic Acids Res. 2004;32 (Database issue):D537-D541 (http//globin.cse.psu.edu).
23. Moreno I, Bolufer GP, Perez SM. The molecular changes in thalassemias in Spain. A review of existing studies. Medicina Clinica. 1999;113(20):789-794.
24. Voon HPJ, Vadolas J. Controlling α-globin: a review of α-globin expression and its impact on β-thalassemia. Haematologica. 2008;93(12):1868-1876.
25. Wonke B. Bone disease in β-thalassaemia major. Br J Haematol. 1998;103(4):897-901.
26. Eldor A, Rachmilewitz EA. The hypercoagulable state in thalassemia. Blood. 2002;99(1):36-43.
27. Walter PB, Macklin EA, Porter J, Evans P, Kwiatkowski JL, Neufeld EJ, et al. Inflammation and oxidant-stress in β-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial. Haematologica. 2008;93(6):817-825. (Pubitemid 351821718)
28. Neufeld EJ. Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions. Blood. 2006;107(9):3436-3441.